Tag: mineralization diseases

Inozyme Pharma Secures 67 Million Series A2 Round Venture Capital

Inozyme Pharma Secures $67 Million in Series A2 Round

by admin

April 10, 2019

Inozyme Pharma, Inc. operates as a biotechnology that focuses on developing novel treatments for rare mineralization disorders. The biotech company ...

No Result

View All Result

Home
News
Video
Stock and Crypto Screener

Tag: mineralization diseases

Inozyme Pharma Secures $67 Million in Series A2 Round

Asure Software (NASDAQ: ASUR) is Expanding to Meet the Rising Demand for Human Capital Management Software

OLB Group (NASDAQ: OLB) and Cuentas (NASDAQ: CUEN) Team Up to Bring Fintech Solutions to Over 32,000 Bodegas Across the United States

New Purchase Orders for SD7 Rugged Device, VK7, and Other Accessories Boost Siyata Mobile’s Outlook (NASDAQ: SYTA)

Telcoin (TEL) Quietly Leads a Crypto Remittance Revolution

Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

Safe-T (NASDAQ: SFET) Has Been Selected to Present at the United Nations’ Office of Information and Communications Technology Event

Safe-T Group (NASDAQ: SFET) Reports Fourth Quarter and Full Year 2020 Financial Results

Safe-T Group Ltd. (NASDAQ: SFET) Estimates Record-High Annual Revenues of Approximately $4.9 Million Representing ~50% Growth YoY 2020

Asure Software (NASDAQ: ASUR) Partners with Harbor Compliance to Help SMBs Streamline Registration Compliance

EVgo (NASDAQ: EVGO) Shares Q4 and FY 2022 Financial Results Showing Massive Revenue Growth, Issues Guidance For 2023

SCYNEXIS (NASDAQ: SCYX) Enters Into Exclusive Agreement with GSK (NYSE: GSK) to Continue Commercializing Brexafemme to Treat Fungal Infections

The Four Pillars of Financial Risk Management

Recent News

EVgo (NASDAQ: EVGO) Shares Q4 and FY 2022 Financial Results Showing Massive Revenue Growth, Issues Guidance For 2023

Categories

Site Navigation